Lipella Pharmaceuticals Overview

Lipella Pharmaceuticals Other Income Expense Net

Other Income/Expense Net for LIPO.

Quarterly Other Income/Expense

$20.19M

↑ 36.65% YoY

As of Sep 30, 2025

Annual Other Income/Expense (TTM)

$41.53M

↑ 43.77% YoY

Trailing 12 months ending Sep 30, 2025

Average Other Income/Expense (Comparison Companies)

Other Income Expense Net History

Other Income Expense Net Comparison

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin